Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Sequential Therapy vs Modified Bismuth Quadruple Therapy for H. pylori Eradication
NCT02159976Completed
- Sponsor
- Seoul National University Bundang Hospital
- Start
- Jul 2014
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of pantoprazole, amoxicillin, tetracycline and bismuth subsalicylate in Helicobacter pylori infection (2 arms), sponsored by Seoul National University Bundang Hospital. Primary endpoint: Counts of Participants With Successful H. Pylori Eradication. Started Jul 2014; status: completed.
02
Drugs
pantoprazoleamoxicillintetracyclinebismuth subsalicylate
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT02159976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02159976.